NEW DELHI: Days after India’s drug regulator suspended manufacturing and marketing permission of Mumbai-based ETOD Pharmaceuticals, which had claimed that their new eye drop reduced dependency on reading glasses for those suffering from presbyopia, an age-related vision condition, on Thursday clarified that it is a “therapeutic option, available only by prescription from the registered medical practitioner.” This paper was the …
The Drugs Controller General of India has given its final approval for ENTOD Pharmaceuticals PresVu eye drops, specifically developed to reduce dependency on reading glasses for individuals affected by presbyopia, a common age-related vision condition that typically impacts those over 40. Presbyopia occurs as a natural consequence of ageing when the eye’s ability to focus diminishes, leading to difficulty in …
